Cari Almo Gallman will take up the reins at Bristol Myers Squibb (BMS) as its new general counsel, chief policy officer and executive vice president.
Gallman has been promoted from within, after serving with BMS for ten years first as senior counsel, and then as assistant general counsel, vice president, senior vice president, chief compliance and ethics officer and most recently as executive vice president of corporate affairs.
She began her legal career as a litigation associate at Debevoise and Plimpton. She holds a law degree from Harvard university.
Gallman succeeds the outgoing Sandra Leung, who is retiring after over three decades at the company.
Christopher Boerner, the chairman of the board at BMS, says: ‘Cari brings a unique combination of legal, policy and communications expertise, coupled with an impressive ability to inspire teams, uphold ethical business practices and champion patient voices.’
Speaking about Leung’s retirement, he adds: ‘Sandy’s resilience, steadfast leadership, and unwavering commitment to patients have left an indelible mark on our company. On behalf of the entire organization, I want to express our deepest gratitude to Sandy for her decades of service and wish her all the best in her well-deserved retirement.’
Gallman adds she is ‘committed to continuing to build on the company’s culture of integrity and shape a dynamic policy environment that protects innovation and patients’.
Talia Samuelson
Talia Samuelson is a reporter for Governance Intelligence. She previously worked as a journalist in Buenos Aires and has covered compliance in Latin America.
